BioCentury
ARTICLE | Clinical News

Mirapex neurology data

May 11, 2009 7:00 AM UTC

Data from a double-blind trial in 301 patients showed that augmentation, defined as an exacerbation of RLS symptoms due to pharmacological treatment, did not significantly differ between pramipexole a...